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Physical exercise can attenuate the effects of aging on the central nervous system by increasing the
expression of neurotrophins such as brain-derived neurotrophic factor (BDNF), which promotes dendritic
branching and enhances synaptic machinery, through interaction with its receptor TrkB. TrkB receptors
are synthesized in the cell body and are transported to the axonal terminals and anchored to plasma
membrane, through SLP1, CRMP2 and Rab27B, associated with KIF1B. Retrograde trafﬁcking is made by
EDH-4 together with dynactin and dynein molecular motors. In the present study it was found that early
neurodegeneration is accompanied by decrease in BDNF signaling, in the absence of hyper-
phosphorylated tau aggregation, in hippocampus of 11 months old Lewis rats exposed to rotenone. It was
also demonstrated that moderate physical activity (treadmill running, during 6 weeks, concomitant to
rotenone exposure) prevents the impairment of BDNF system in aged rats, which may contribute to delay
neurodegeneration. In conclusion, decrease in BDNF and TrkB vesicles occurs before large aggregate-like
p-Tau are formed and physical activity applied during early neurodegeneration may be of relevance to
prevent BDNF system decay.
© 2016 The Authors. This is an open access article under the CC BY license (http://creativecommons.org/
licenses/by/4.0/).1. Introduction
Alzheimer's disease (AD) is the most common cause of de-
mentia, characterized by progressive neurodegeneration. AD is
characterized by the presence of amyloid-beta (Ab) deposits in the
form of senile plaques and the intraneuronal aggregation of
hyperphosphorylated tau, a microtubule-associated protein, in
hippocampus (Schindowski et al., 2008; Simic et al., 2016). These
aggregates seem to be associated with a variety of cellular insults
like synaptic failure, dysregulation of intracellular signaling cas-
cades, disruption of axonal transport, oxidative stress and mito-
chondrial dysfunction (Hashimoto et al., 2003). However, it
remains uncharacterized whether protein aggregation is the direct
cause of neuronal death or there are cellular events that occur in
the absence of protein aggregated and collaborate for cell damage.
It is well accepted that oligomers, which are the early stages of
protein aggregation, might be more toxic than protein inclusions,e Biologia Evolutiva, Instituto
ao, 277, Cidade Universitaria,
(M.F.R. Ferrari).
s article under the CC BY license (since they may disrupt axonal transport as well as spread tau
oligomeric seeds (Chung et al., 2001; Hoover et al., 2010; Lasagna-
Reeves et al., 2010; Flach et al., 2012; Xie and Chung, 2012; Riemer
and Kins, 2013).
Maintenance of neuronal function, neuroplasticity, morpho-
genesis and survival are ensured by axonal transport of vesicles,
mitochondria, neuroﬁlaments and other cell components (Decker
et al., 2010; Hirokawa et al., 2010). Thus dysregulation of traf-
ﬁcking has signiﬁcant physiological consequences in neurons, such
as synaptic dysfunction. Moreover, early stages of AD are charac-
terized by disruption in axonal transport, corroborating with the
disease pathophysiology (Muresan and Muresan, 2009; Goldstein,
2012; Millecamps and Julien, 2013).
Several previous studies demonstrated decreased spine growth,
synaptic transmission, loss of memory and learning difﬁculties by
disruption on transport of brain-derived neurotrophic factor
(BDNF) and its receptors (Kennedy et al., 2010; Lu et al., 2013; Yoshii
et al., 2013).
BDNF is the major brain neurotrophin. It is involved in neuronal
differentiation, maturation and survival; it modulates synaptic
transmission and neuronal plasticity (Sebastiao et al., 2011).
Intracellular signaling of BDNF involves activation of tropomyosin-
related kinase B (TrkB) receptor, which may be associated to ahttp://creativecommons.org/licenses/by/4.0/).
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independent of kinase activity (TrkB-truncated; TrkB-tc), and
activation of PLCg, PI3K/Akt, and ERK/MAPK pathways (Friedman,
2000; Patapoutian and Reichardt, 2001; Numakawa et al., 2010;
Luine and Frankfurt, 2013; Kellner et al., 2014).
BDNF and TrkB-ﬂ receptors levels decrease during aging
(Webster et al., 2006; Diogenes et al., 2007; Lee et al., 2009), in AD
their levels are further reduced (Ginsberg et al., 2006; Kao et al.,
2012). Therefore, impaired transport and low expression of BDNF
might contribute to synaptic dysfunction in AD (Khatri and Man,
2013; Scharfman and Chao, 2013). However, it remains poorly un-
derstood whether impaired axonal transport is cause or conse-
quence of reduced BDNF signaling, and whether this is affected
during the course of protein aggregation.
In neurons, anterograde trafﬁcking of TrkB receptors is done by
the interaction among Slp1, Rab27B and CRMP-2 proteins that
direct link TrkB to the molecular motor Kinesin-1 (Arimura et al.,
2009; Hirokawa et al., 2010). For retrograde trafﬁcking, Pincher
(EDH-4) and Rab5 are proteins that interact with the dynein/
dynactin complex (Valdez et al., 2005; Zweifel et al., 2005;
Hirokawa et al., 2010; Philippidou et al., 2011).
Physical exercise is postulated to promote neurogenesis through
increase in BDNF levels, as well as increasing the levels of some
proteins involved in axonal trafﬁcking (Molteni et al., 2002;
Ploughman, 2008; Erickson et al., 2012). Furthermore, physical
exercise prevents other common features of aging, such as hippo-
campal atrophy, loss of memory and depression (Ogonovszky et al.,
2005; Webster et al., 2006; Diogenes et al., 2007; Luellen et al.,
2007; Lee et al., 2009; Marais et al., 2009; Erickson et al., 2012).
However, the importance of physical exercise and the role of early
protein aggregation in modulating axonal transport of BDNF and
TrkB receptors during ageing and neurodegeneration are not well
understood.
In view of this, it is hypothesized that BDNF levels, trafﬁcking
and signaling are disrupted in early neurodegeneration and phys-
ical exercise might interfere in this system.
2. Material and methods
Experiments were conducted in agreement with the Interna-
tional Guideline for Animal Experimentation care and use (Demers
et al., 2006), and the Brazilian federal animal welfare law 11794/08.
Procedures were approved by the research ethics committee (CEUA
121/11 and 451/11) of the Institute for Biosciences, University of Sao
Paulo.
2.1. Animals, rotenone exposure and physical exercise
Twenty aged male Lewis rats (9 months old), supplied by the
central animal facility of the Institute of Biosciences of the Uni-
versity of Sao Paulo, were housed in groups of 3e4 animals per
conventional cage, maintained at 23 C ± 2, in an inverted 12 h light/
12 h dark cycle (lights off at 6 a.m.), with free access to food and
water.
Animals had osmotic minipumps (Alzet) implanted subcutane-
ously, between their scapulae, under anesthesia with ketamine
(1.25 ml/kg) and xylazine (0.5 ml/kg). Minipumps were ﬁlled either
with rotenone (Sigma, USA) dissolved in equal volumes of dimethyl
sulfoxide (DMSO, Sigma, USA) and polyethylene glycol (PEG, Sigma,
USA)whichwas delivered at the rate of either 1mg/kg/day during 8
weeks (n ¼ 10 animals), or only DMSO:PEG (1:1, n ¼ 10 animals) as
control. Minipumps were replaced at week 4 to guarantee 8 weeks
of treatment.
One week after minipumps implant, all Lewis rats were famil-
iarized to treadmill during 3 weeks, 3/week, 30 min/day. Afterthis, rats were preselected according to their ability to run in a
treadmill and allocated to aerobic training (EXE, 50e60% of
maximal exercise capacity, 5 days/week, 40 min/day, during 6
weeks) or kept sedentary (SED).
Maximal exercise capacity was determined by the maximal
exercise test (starting at 0.3 km/h, with increments of 0.3 km/h
every 3 min until exhaustion), which was repeated every 2 weeks
in order to maintain training intensity.
Those rats that did not run or stopped running during protocol
were excluded from the analysis. Rats were then divided in 4
groups (n ¼ 5): DMSO-SED, DMSO-EXE, ROT-SED and ROT-EXE.
After treatment, animals were euthanized and their hippo-
campus removed and stored at 20 C in protein extraction buffer
(400 ml of PBS, pH 7.4, containing 1% NP40, 0.5% sodium deoxy-
cholate, 1% SDS, 1 mM EDTA, 1 mM EGTA and 1% protease inhibitor
cocktail, Sigma).2.2. Primary neuronal cell culture and rotenone exposure
Cell culture method was described in detail elsewhere (Kivell
et al., 2001). Brieﬂy, for each experimental group, 20 neonatal (1
day-old) Lewis rats were decapitated and their hippocampus was
dissected out, dissociated in sterile cold solution consisted of
120 mM NaCl, 5 mM KCl, 1.2 mM KH2PO4, 1.2 mM MgSO4, 25 mM
NaHCO3, 13 mM glucose, pH 7.2, and subjected to mechanical and
chemical cell decoupling. Solution containing cells was centrifuged
at 300 g for 5 min. Supernatant was discarded and cells were
suspended in Neurobasal A medium (Gibco) supplemented with
0.25 mM Glutamax (Gibco), 2% B27 (Gibco); 0.25 mM L-Glutamine
(Sigma) and 40 mg/L Gentamicin (Gibco).
Cells were plated on 24-well plate (Nunc) or confocal dishes,
coated with poli-D-lysine, at the concentration of 1800 cells/mm2.
Cultures were kept in a humidiﬁed incubator with 5% CO2 at 37 C
for nine days with medium changed every three days of cultivation.
Rotenone was prepared with DMSO and diluted in culture me-
dium applied to cell cultures in concentrations of 0.3, 0.5 and
1.0 nM for 48 h, control cultures were exposed to DMSO diluted in
culture medium, all cells were exposed to at most 0.001% DMSO.2.3. Western blot
Brain tissues were homogenized in extraction buffer and
centrifuged at 14000 rpm for 20min; the resulting supernatant was
fractionated by SDS-PAGE (15 mg of protein/lane) using a 12% tris-
HCl gel at 100 V for 1 h. Proteins were transferred to nitrocellu-
lose membrane in transfer buffer (25 mM Tris, 190 mM glycine, 10%
methanol) for 1 h at 100 V at 4 C. Membranes were blocked for 1 h
at room temperature in Tris-Buffered saline containing Tween 20
(TBS-T; 50 mM Tris, pH 8.0, 133 mM NaCl, 0,2% Tween 20) with 5%
non-fat dry milk or 3% BSA (Sigma).
Blots were incubated with primary antibodies against BDNF (N-
20, sc-546, Santa Cruz, 1/500); TrkB (H-181, sc-8316, Santa Cruz, 1/
1000); SLP-1 (sc-136480, Santa Cruz, 1/2000); CRMP-2 (C2993,
Sigma, 1/7000); Rab-27B (R-4655, Sigma, 1/1000); EDH-4 (NBP1-
54873, Novus, 1/1000); KIF1B (L-20, sc-18739, Santa Cruz, 1/200);
Dynein (R-325, sc-9115, Santa Cruz, 1/200); Dynactin (H-300, sc-
11363, Santa Cruz, 1/400); AKT (9272, Cell Signaling, 1/2000);
pAKT (ser-473, Cell Signaling, 1/750), NeuN (MAB377, Millipore, 1/
500), JNK (9258, Cell Signaling,1/1000) or p53 (2524, Cell Signaling,
1/500), in 3% non-fat dry milk or 1% BSA in TBS-T, overnight at 4 C,
followed by horseradish peroxidase-conjugated anti-mouse (1/
6000, Amersham), anti-goat (1/5000, Amersham) or anti-rabbit (1/
10000, Amersham). Secondary antibodies incubations were per-
formed at room temperature during 1 h.
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chemiluminescence reagent (Millipore) and exposure to chemo-
luminescence sensitive ﬁlms (Hyperﬁlm ECL, Amersham Bio-
sciences). After development, blots were incubated with anti-beta-
actin antibody (sc-47778, Santa Cruz, 1/1000) during 1 h at room
temperature, followed by horseradish peroxidase conjugated anti-
mouse (1/6000, Amersham), 1 h at room temperature, and were
developed as previously described. Beta actin values were used for
loading control and normalization.
Membranes for JNK and p53 analysis were stainedwith Ponceau
S solution (Sigma), prior to blocking with 5% non-fat dry milk, for
JNK and p53 normalization.
Films and Ponceau stained membranes were quantiﬁed using
Image J software (NIH).
2.4. Immunocytochemistry for hyperphosphorylated Tau and MAP-
2
Neurons were ﬁxed in 50%methanol and 50% acetone for 10min
at 20 C, rinsed with PBS and permeabilized with 0.2% triton X-
100 in PBS for 30 min. Non speciﬁc binding was blocked with 2%
normal goat serum and 4% BSA in PBS for 30 min and then incu-
bated overnight with primary antibodies against hyper-
phosphorylated Tau (1/1000, Sigma, Ser 199/202, T6819, raised in
rabbit) or MAP2 (neuron marker, 1/1000, sc 74422; Santa Cruz,
raised in mouse) in 1% NGS, 2% BSA and 0.2% triton X-100. Dishes
were washed with cold PBS followed by incubation with FITC or
Texas red conjugated secondary antibody for 2 h. Cells were
mountedwithmountingmedium containing DAPI (40,6-diamidino-
2-phenylindole, Vector laboratories).
2.5. Axonal trafﬁcking of BDNF-containing vesicles
Primary neurons were transfected with pb-actin-BDNF-mRFP
plasmid (kindly provided by Professor Michael A. Silverman, Simon
Fraser University, Canada) using Lipofectamine 2000. Movement of
BDNF-containing dense core vesicles was evaluated 48 h post-
transfection in neurons cultured in phenol red free medium, us-
ing a Carl Zeiss LSM780 inverted Multiphoton microscope with an
integrated live cell chamber allowing 5% of CO2 and 37 C envi-
ronment, using the 63 objective.
Individual axons were identiﬁed according with their distin-
guishable morphological features, BDNF transport was evaluated in
100 mM length area through time-series of 121 images taken with
1 s interval and exposure of 100 ms from three neurons of different
ﬁelds, per sample plate (n ¼ 3 plates from 5 different cell cultures,
or as indicated in graph bars). Movies were built using ImageJ and
analyzed using difference tracker plugin as described by Andrews
et al. (2010). Total BDNF moving tracks were accessed as well as
the direction of these tracks allowing the evaluation of retrograde
or anterograde trafﬁcking.
2.6. Neurons morphology and neurites length analysis
Neurons morphology and neurites length were accessed
through immunocytochemistry assays accordingly with the previ-
ously described protocol (Ho et al., 2011). Brieﬂy, after exposure to
rotenone neurons were ﬁxed and permeabilized as described for
immunocytochemistry for hyperphosphorylated Tau and MAP-2.
Cells were incubated overnight with primary antibody against
MAP2 (1/1000) followed by incubationwithmouse FITC conjugated
secondary antibody for 2 h, mounted with mounting medium
containing DAPI and imaged on Carl Zeiss LSM780 inverted
Multiphotonmicroscope using the 20 objective. Images from four
randomly selected ﬁelds per plate from 3 different cultures weretaken and the quantitative analysis of immunoﬂuorescence data
was performed using Image J (NIH) and the plug-in NeurphologyJ,
as described previously, using MAP2 as a marker for neurites (Ho
et al., 2011).
2.7. Statistical analysis
One-way or two-way ANOVA followed by Bonferroni post-hoc
test accessed through GraphPad Prism (GraphPad Software Inc.,
version 5.00, CA) was employed to analyze results. Data are
expressed as percent of control (DSMSO) ± standard deviation (SD).
A p-value  0.05 was considered to indicate statistically signiﬁcant
differences.
3. Results
3.1. Hyperphosphorylated Tau and cell viability remains unchanged
in the presence of low doses of rotenone and moderate physical
activity
These experiments were done to evaluate the effects of low
doses of rotenone upon Tau aggregation and cell death, in order to
ensure the evaluation of early neurodegeneration. Aged Lewis rats
exposed to rotenone do not show signiﬁcant differences in Tau
hyperphosphorylation (Fig. 1A and B). Moderate physical exercise
also does not change pTau levels (Fig. 1A and B) or the aggregation
as demonstrated by the absence of higher molecular weight bands
in Fig. 1A.
Neuronal loss was evaluated by quantiﬁcation of Neu-N, JNK and
p53 levels, it was shown that rotenone at low concentrations, as
well as moderate physical activity do not change neuron viability
(Fig. 1A, CeF).
3.2. BDNF and TrkB levels in the hippocampus of exercised aged
Lewis rats during early neurodegeneration
BDNF levels decrease in hippocampus of aged Lewis rats in the
absence of large aggregate-like p-Tau, however physical exercise
prevents this decrease and raises the levels of BDNF about 40% over
DMSO sedentary rats (Fig. 2A and B).
TrkB full length increases 200% in the absence of aggregate-like
p-Tau, physical activity alone also increases this TrkB isoform
(300%), combination of rotenone and physical exercise promotes an
increase of 150% of TrkB-ﬂ receptor (Fig. 2A and C).
On the other hand, TrkB truncated, which might have inhibitory
effects upon TrkB-ﬂ, was also elevated 150% in hippocampus of
aged Lewis rats exposed to rotenone and to physical activity prac-
tice (Fig. 2A and D).
3.3. Trafﬁcking of TrkB vesicles in the hippocampus of exercised
aged Lewis rats during early neurodegeneration
The levels of SLP-1, CRMP-2, Rab27bB, KIF1B were measured in
order to evaluate anterograde trafﬁcking of TrkB receptors. The
levels of speciﬁc protein complex related to anterograde trafﬁcking
of TrkB vesicles (SLP-1 and Rab27B) decreased before major
hyperphosphorylation of Tau (35% for SLP-1 and 50% for Rab27B),
whereas physical activity prevented this decrease (Fig. 3A, B and C).
CRMP-2 increased 40% in early neurodegeneration, which was
potentialized (raise of 100%) by physical activity (Fig. 3A and D).
KIF1B did not change in the present experimental protocol (Fig. 3A
and E).
Retrograde trafﬁcking of TrkB receptors was evaluated by the
expression of EDH-4, dynactin and dynein. EDH-4 is 80% increased
in early neurodegeneration and in the presence of physical activity
Fig. 1. Hyperphosphorylated Tau (pTAU), Neu-N, JNK and p53 levels in hippocampus of 11 months old rats exposed to rotenone (ROT, 1 mg/kg/day) or DMSO (control), during 8
weeks, and exercised during 6 weeks (EXE) or left sedentary (SED). It is shown the absence of high molecular weight bands for pTau (A) and the lack of alterations for proteins
associated with cell loss (A, CeF). Values were normalized by beta-actin (B and C) or Ponceau staining (E and F), expressed as percentage of control (DMSO sedentary) ± S.D. Means
were compared through two-way ANOVA followed by Bonferroni ad-hoc test. n ¼ 5.
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(Fig. 3A and G) and dynein was not altered in the present study
(Fig. 3A and H).3.4. Immunolabeling of hyperphosphorylated Tau in cultured
hippocampal cells
Immunocytochemical labeling of hippocampal cultures showed
that cultures exposed to 1 nM rotenone present p-Tau labeling
mainly localized towards the cell body, suggesting mislocation
(Fig. 4). Rotenone at 1 nM also promoted aggregate-like pattern of
p-Tau labeling, demonstrated by the puncta labeling (Fig. 4,
arrows).3.5. Decrease in trafﬁcking of BDNF-containing vesicles in early
neurodegeneration and during cell death in primary hippocampal
cell culture
After observing alterations in the levels of proteins associated
with trafﬁcking of TrkB vesicles, the next step was to analyze the
transport of BDNF-containing vesicles in live cells. Axonal trafﬁcking
of BDNF-containing vesicles was decreased (30%) in the absence of
major hyperphosphorylation of Tau (ROT 0.3 nM, Fig. 5A and B). It is
interesting to note that during the increase of p-Tau (0.5 nM rote-
none) there is normalization of axonal trafﬁcking (Fig. 5A and B). In
the presence of large aggregate-like conformation of p-Tau and
beginning of cell death (ROT 1.0 nM) trafﬁcking of BDNF vesicles is
impaired (Fig. 5A and B). Anterograde and retrograde trafﬁcking is
decreased during early neurodegeneration (Fig. 5A, C and D),
whereas this dysfunction at late stages of p-Tau accumulation is
present only in retrograde trafﬁcking (Fig. 5A and D).
Fig. 2. BDNF, TrkB-ﬂ (full length) and TrkB-tc (truncated) levels in hippocampus of 11 months old rats exposed to rotenone (ROT, 1 mg/kg/day) or DMSO (control), during 8 weeks,
and exercised during 6 weeks (EXE) or left sedentary (SED). Representative images of immunoblot bands corresponding to BDNF, TrkB-ﬂ, TrkB-tc and beta-actin (A). Quantiﬁcation
of BDNF (B), TrkB-ﬂ (C) and TrkB-tc (D) expression. Values were normalized by beta-actin, expressed as percentage of control (DMSO sedentary) ± S.D. Means were compared
through two-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05 as compared with the DMSO from the same physical activity protocol (sedentary or exercised); #p < 0.05 as
compared with sedentary exposed to the same drug protocol (DMSO or Rotenone) n ¼ 5.
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culture during accumulation of p-Tau
In order to compare the effects of rotenone upon the levels of
BDNF and TrkB receptors between aged rats and cell culture, these
parameters were evaluated by western blot. BDNF levels did not
change after rotenone exposure, although at 0.3 nM (before to
accumulation of p-Tau) there is a tendency of decrease (30%) in its
levels (p ¼ 0.07, Fig. 6A and B). TrkB full length decreased 40%
before and during to accumulation of p-Tau (Fig. 6A and C), whereas
truncated isoform of TrkB receptor increases in the presence of
aggregate-like p-Tau (0.5 and 1 nM rotenone, Fig. 6A and D).
3.7. Levels of proteins involved in anterograde trafﬁcking of TrkB in
cultured hippocampal cells
Trafﬁcking of BDNF receptors was also evaluated by studying the
levels of proteins involved in this transport. Complex SLP-1/Rab27B
is increased before accumulation of p-Tau and during the early
aggregation (ROT 0.3 nM and 0.5 nM, respectively, Fig. 7A, B and C),
whereas there is no change in the levels of these proteins after p-
Tau deposits (ROT 1.0 nM, Fig. 7AeC). CRMP-2 levels did not change
after rotenone exposure (Fig. 7A and D).
3.8. TrkB-ﬂ/BDNF signaling pathway
Although changes in TrkB-ﬂ and BDNF levels were found in the
present study, the real physiological signiﬁcance is measured by
activation of intracellular cascades. TrkB-ﬂ/BDNF signaling pathway
was investigated by measuring phosphorylation of AKT. It was
demonstrated a decrease in pAKT levels during rotenone exposure,
with the lowest levels (decrease of 70%) being encountered in the
absence of p-Tau deposits (0.3 nM rotenone, Fig. 8A and B).3.9. Neurite quantiﬁcation
The latter consequence of disturbance in BDNF system may be
fragmentation of neuron prolongations. To test this hypothesis,
neurite count and length were quantiﬁed. Confocal microscopy of
primary hippocampal cell culture showed that accumulation of
insoluble p-Tau triggered expressive neurite fragmentation
compared to control (Fig. 9A). Quantiﬁcation of branch number
demonstrated an increase of 10% in neurite count after increased p-
Tau (ROT 0.5 nM, Fig. 9B), accompanied by decrease in neurite
length (Fig. 9C), suggesting that dendrite/axon fragmentation oc-
curs during p-Tau accumulation promoted by rotenone exposure.
4. Discussion
In the present study it was demonstrated, for the ﬁrst time, that
alterations in BDNF/TrkB levels, signaling and trafﬁcking precede
any change in hyperphosphorylation of Tau in hippocampus of aged
rats exposed to rotenone. It was also shown that moderate physical
activity prevents the impairment of BDNF system in aged rats,
which may be one contributing factor to delay neurodegeneration
(Colcombe et al., 2003).
Rotenone is a speciﬁc inhibitor of mitochondrial complex I, it
was employed in the present study to simulate the different phases
of protein aggregation, as can be found in early neurodegeneration.
It was demonstrated previously that rotenone is able to promote
“in vitro” and “in vivo” aggregation and hyperphosphorylation of
tau without causing cell death (Hoglinger et al., 2005; Radad et al.,
2008; Ullrich and Humpel, 2009; Chaves et al., 2010, 2013; Melo
et al., 2013). Several recently published studies conﬁrmed the ac-
curacy of Neu-N levels, measured by Western blot, alone or
comparedwith immunolabeled neurons or caspase 3 levels, to infer
about cell loss (Zhang et al., 2013; Murphy et al., 2014; Cheng et al.,
Fig. 3. Trafﬁcking proteins levels in hippocampus of 11 months old rats exposed to rotenone (ROT, 1 mg/kg/day) or DMSO (control), during 8 weeks, and exercised during 6 weeks
(EXE) or left sedentary (SED). Representative images of immunoblot bands corresponding to SLP-1, Rab27B, CRPM-2, KIF1B, EDH-4, Dynactin, Dynein and beta-actin (A). Quan-
tiﬁcation of SLP-1(B), Rab27B (C), CRMP-2 (D), KIF1B (E), EDH-4 (F), Dynactin (G) and Dynein (H) expression. Values were normalized by beta-actin, expressed as percentage of
control (DMSO sedentary) ± S.D. Means were compared through two-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05 as compared with the DMSO from the same physical
activity protocol (sedentary or exercised); #p < 0.05 as compared with sedentary exposed to the same drug protocol (DMSO or Rotenone) n ¼ 5.
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Fig. 4. Illustrative digital images of cultured hippocampal neurons labeled with antibodies against MAP2 and hyperphosphorylated Tau (p-TAU) after exposure to DMSO (control),
0.3, 0.5 or 1 nM of rotenone during 48 h. Note the decrease in size and number of neuronal branches evidenced after 1 nM rotenone treatment. Dense p-Tau aggregates-like are
found in neuronal cells exposed to 1 nM rotenone (arrows). Scale bar ¼ 50 mm.
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levels of JNK and p53 to demonstrate that there is no neuron loss in
the present experimental protocol.Aged rats exposed to 1 mg/kg/day of rotenone, as well as
physical exercise, do not present differences in p-Tau as demon-
strated herein, validating the hypothesis that the changes in BDNF
Fig. 5. Axonal trafﬁcking of BDNF-containing vesicles in hippocampal primary cell cultures exposed to rotenone (ROT, 0.3 nM, 0.5 nM or 1.0 nM) or DMSO (control), during 48 h.
Representative kymographs comparing axonal trafﬁcking of BDNF-containing vesicles in DMSO, 0.3 nM ROT, 0.5 nM ROT or 1.0 nM ROT (A). Quantiﬁcation of BDNF vesicles track
count (B), BDNF vesicles anterograde count (C) and BDNF vesicles retrograde count (D). Values were expressed as percentage of control (DMSO) ± S.D. Means were compared
through one-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05; **p < 0.01 as compared with DMSO. Number in each column represents the number of cells considered to
count vesicles movements.
Fig. 6. BDNF, TrkB-ﬂ and TrkB-tc levels in hippocampal primary cell cultures exposed to rotenone (ROT, 0.3 nM, 0.5 nM or 1.0 nM) or DMSO (control), during 48 h. Representative
images of immunoblot bands corresponding to BDNF, TrkB-ﬂ, TrkB-tc and beta-actin (A). Quantiﬁcation of BDNF (B), TrkB-ﬂ (C) and TrkB-tc (D) expression. Values were normalized
by beta-actin, expressed as percentage of control (DMSO) ± S.D. Means were compared through one-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05 as compared with
DMSO; #p < 0.05 as compared with 0.3 nM n ¼ 3 independent cultures, run in technical triplicates.
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Fig. 7. Molecular proteins levels in hippocampal primary cell cultures exposed to rotenone (ROT, 0.3 nM, 0.5 nM or 1.0 nM) or DMSO (control), during 48 h. Representative images of
immunoblot bands corresponding to SLP-1, Rab27B, CRPM-2, and beta-actin (A). Quantiﬁcation of SLP-1(B), Rab27B (C) and CRMP-2 expression. Values were normalized by beta-
actin, expressed as percentage of control (DMSO) ± S.D. Means were compared through one-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05 as compared with DMSO.
n ¼ 3 independent cultures, run in technical triplicates.
Fig. 8. Phosphorylated AKT and AKT levels in hippocampal primary cell culture exposed to rotenone (ROT, 0.3 nM, 0.5 nM or 1.0 nM) or DMSO (control), during 48 h. Representative
images of immunoblot bands corresponding to pAKT, AKT and beta-actin (A). Quantiﬁcation of pAKT/AKT ratio (B) expression. Values were normalized by beta-actin, expressed as
percentage of control (DMSO) ± S.D. Means were compared through ane-way ANOVA followed by Bonferroni ad-hoc test. *p < 0.05 as compared with DMSO. n ¼ 3 independent
cultures, run in technical triplicates.
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hippocampal cells, exposure to 1 nM of rotenone during 48 h in-
duces hyperphosphorylation of tau mimicking cellular dysfunc-
tions present in AD. On the other hand, exposure to 0.3 nM
rotenone does not change hyperphosphorylation of Tau, and 0.5 nM
during 48 h induces oligomerization of hyperphosphorylated tau
without triggering major protein aggregation (Chaves et al., 2010).
Thus, rotenone exposure protocol employed in the present study
for rats is comparable to the lowest concentration applied in hip-
pocampal cell culture (0.3 nM) considering its effects upon hyper-
phosphorylation of Tau.
There is a number of different physical exercise protocols
applied to different animal models of neurodegeneration. Results
largely disagree about the effects of physical activity upon the
central nervous system during the neurodegenerative process (Lin
et al., 2015; Elahi et al., 2016), however the majority of theseprevious studies evaluated physical activity as a method to treat
neurodegeneration already installed. Our present study intends to
add some knowledge upon the process before the ﬁrst signs of
neurodegeneration appear.
BDNF signaling seems to be elevated by physical activity in the
hippocampus of aged rats in the presence of a neurodegenerative
insult, as previously described elsewhere (Coelho et al., 2014), the
present study is of relevance since it shed light on the mechanism
by which moderate physical activity may be acting to delay neu-
rodegeneration associated to protein aggregates.
The increase in TrkB-ﬂ receptor levels in sedentary rats during
early neurodegeneration may be a response to the decreased levels
of BDNF before aggregate-like p-Tau is formed, as a mechanism of
feedback between these proteins. In fact, autocrine mechanism of
BDNF signaling has long been described (Kokaia et al., 1993), in that
context we hypothesize that there might be a compensatory
Fig. 9. Neurons morphology and neurites length. Illustrative digital images of hippocampal primary cell culture exposed to rotenone (ROT, 0.3 nM or 0.5 nM) or DMSO (control),
during 48 h (A), labeled with anti MAP-2 (upper panels) and subjected to ImageJ for neurite track (bottom panels). Quantiﬁcation of neurite count (B) and neurite length (C). Means
were compared through one-way ANOVA followed by Bonferroni ad-hoc test. **p < 0.01 as compared with DMSO. n ¼ 3 independent cultures, run in technical triplicates. Bar
scale ¼ 300 mm.
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This is evidenced by the decrease of TrkB levels after physical ex-
ercise that increased BDNF levels in the presence of rotenone.
Moreover, physical activity improves BDNF signaling by elevating
BDNF and TrkB-ﬂ levels during early neurodegeneration.
Speciﬁcally about the function of truncated isoform of TrkB, it is
still controversial in literature. TrkB-tc may be associated with
recycling of BDNF (Fenner et al., 2014), other studies demonstrate
that TrkB-tc decrease the function of TrkB-ﬂ (Salehi et al., 2006). It
seems that the role of TrkB-tc depends upon the presence of BDNF,
since in the presence of this neurotrophin, TrkB-tc is associated
with cell survival response, whereas in the absence of BDNF TrkB-tc
may contribute to cell death and acts as dominant negative inhib-
itor of TrkB-ﬂ (Gomes et al., 2012).
In the present study the increase of TrkB-tc was accompanied by
decrease of TrkB-ﬂ, without changes in BDNF levels, which was
related to neurite fragmentation, corroborating the idea of an
antagonistic relation between the full length and truncated isoform
of TrkB.
In agreement with the idea of BDNF signaling improvement by
physical activity during early neurodegeneration, in the present
study it was demonstrated for the ﬁrst time that physical exercise
prevents the decrease in trafﬁcking proteins associated with BDNF
and TrkB receptors anterograde and retrograde axonal transport,
present during neurodegeneration (Chaves et al., 2013; Melo et al.,
2013), these previously published data refers to aged rats exposed
to one month of rotenone exposure, the present study shows data
from aged rats exposed to two months of rotenone, this may
explain the supposed difference in the expression of KIF1B and
dynactin.
Primary hippocampal cell cultures were exposed to low and
moderate doses of rotenone in order to investigate the mechanisms
underlying BDNF and TrkB receptors levels and trafﬁcking beforeand during hyperphosphorylation of Tau. However, since it is not
possible yet to reproduce ageing in primary cell culture, and many
of the results are related to ageing itself in brain of aged rats, there
are several results that do not corroborate with in vivo data.
Another important fact that must be taken into account is that
rotenone delivered subcutaneously might not be as concentrated in
brain as it is in plasma, furthermore, time of exposure also may not
be comparable between the two experimental models.
Moreover, Perovic et al. (2013) described that hippocampal
BDNF mRNA expression was lower in 12-month-old rats as
compared with young rats, moreover, the levels of p-Akt and pro-
tein kinase C were decreased in aged rats. This is evidence that
aging, per se, is an insult to BDNF system, indicating that the basal
situation (control groups) cannot be compared between cultures
and in vivo models. BDNF system in cultured neurons is affected
only by rotenone, thus it seems that rotenone acts preferably upon
trafﬁcking (probably because of the presence of oligomers) and
levels of TrkB receptors. Aged rats, on the contrary, are subjected to
rotenone besides the aging process, in this context BDNF levels
decreased (probably because there are two effectors). In summary,
low levels of rotenone is able to interfere with trafﬁcking, whereas
in the presence of the aging process there are more pronounced
effects upon BDNF availability. The differences encountered for
cultures and aged rats is not at all invalidated, since it is demon-
strated in vitro and in vivo that alteration in cell physiology is
already established in the absence of Tau hyperphosphorylation.
The present study demonstrates for the ﬁrst time a decrease in
trafﬁcking of BDNF-containing vesicles, mainly in retrograde di-
rection, even in the absence of protein aggregates. Impairment of
BDNF signaling is corroborated also by the decrease on TrkB-ﬂ
levels, before large p-Tau aggregate-like forms.
It is interesting to point out that the decrease in BDNF trafﬁcking
is accompanied increase of speciﬁc proteins, such as SLP-1 and
Fig. 10. Graphical abstract depicting decrease in BDNF/TrKB signaling during early neurodegeneration, which is restored with moderate physical exercise.
M.F. Almeida et al. / IBRO Reports 1 (2016) 19e31 29Rab27B, related to trafﬁcking of TrkB receptors. This controversy
may be partially explained by the compensatory cellular feedback
in response to decrease in BDNF signaling. SLP-1 and Rab27 areproteins related to anterograde trafﬁcking of TrkB receptors, espe-
cially at the ﬁnal portion of axon terminal, since these proteins use
actin cytoskeleton (Johnson et al., 2012). One could hypothesize
M.F. Almeida et al. / IBRO Reports 1 (2016) 19e3130that this is an attempting to increase TrkB receptors at synaptic
terminal to improve BDNF signaling.
Moreover, increased intracellular calcium concentrations are
reported in the presence of Ab oligomers (Decker et al., 2010; Gan
and Silverman, 2015), which is associated with early pathological
manifestations in AD (Berridge, 2011).
BDNF signaling was evaluated by the ratio of phosphorylated
AKT by total AKT, conﬁrming the decrease of BDNF signaling in the
absence of aggregate-like hyperphosphorylated Tau. Reduction on
pAKT/AKT ratio correlates with neuron loss in cultured primary
mouse neurons, in old 3xTg-ADmice (Ghosh and Brewer, 2014) and
in APP/PS1 mice (Li and Liu, 2010). Alterations in pAKT/AKT ratio
have also been reported in AD (Liu et al., 2013; Ong et al., 2014). This
may be of relevance for cell death, as one of the features of neu-
rodegeneration is fragmentation of neurites, as demonstrated in
the present study when the ﬁrst aggregates appear (0.5 nM rote-
none). BDNF signaling also involves the activation of ERK and
CaMK, besides AKT, which were not evaluated in the present study;
and is probably involved in the BDNF signaling after 0.5 nM rote-
none exposure, as it was not observed any change in AKT whereas
TrkB-ﬂ levels were reduced at this concentration.
Is it hypothesized that biochemical changes occur before neurite
fragmentation, and those imbalance would lead to fragmentation
in a latter period. It was previously shown that 0.3 nM applied for
72 h has the same effects as 0.5 nM during 48 h, so the effects of
0.3nM/48 h would accumulate and cause neurite fragmentation at
72 h incubation (as demonstrated with 0.5nM/48 h). This is
emphasized that BDNF trafﬁcking was evaluated in intact cell
branches, demonstrating that trafﬁcking is not altered in the
presence of the ﬁrst aggregates in intact cells.
In conclusion, there is evidence that BDNF signaling is impaired
in the absence of large aggregate-like p-Tau forms, probably by the
decrease of BDNF and TrkB vesicles trafﬁcking, and moderate
physical activity applied during early neurodegeneration may be of
relevance to prevent this decline of BDNF system. Fig. 10 summa-
rizes the results of BDNF trafﬁcking and signaling in early neuro-
degeneration, as well as the effects of moderate physical activity
upon BDNF pathways.
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